A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Clinical trial NCT02550535 · COMPLETED

Trial details

NCT number: NCT02550535
Sponsor: Cell Medica Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)

Start date: 2015-09-01
Primary completion: 2018-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.